Kagome just dropped its Q3 2026 scorecard and the stock closed at ¥2,738.5 on Friday, barely moved over the past week despite a sharp inflection in profit. Basic earnings per share landed at ¥42.73 on revenue of ¥82,881m, putting the spotlight squarely on earnings power rather than top line.
The market looks cautious. A 7 day return that slipped almost 2% clashes with a quarter where net income excluding extra items reached ¥3,865m. Right now emotion is lagging the numbers, and the key development is a clear profit upswing rather than any dramatic margin squeeze or balance sheet stress.
Like Kagome’s earnings rebound but want more stocks where improving profits are already attracting fresh interest rather than getting shrugged off by the market? Check out our hand picked 15 high quality undervalued stocks as a benchmark list of companies pairing solid fundamentals with cautious pricing.
Q3 2026 Earnings Summary
- Revenue (Q3 2026 vs. Q3 2025): ¥82,881m vs. ¥77,628m (up about 6.8%)
- Net Income Excl. Extra Items (Q3 2026 vs. Q3 2025): ¥3,865m vs. ¥4,500m (down about 14.1%)
- Basic EPS (Q3 2026 vs. Q3 2025): ¥42.73 vs. ¥49.52 (down about 13.7%)
- Net Profit Margin, Trailing 12 Months: 4.2%, roughly unchanged from the prior year (stable profitability level)
Earnings tell you what Kagome booked this quarter, but cash flows show what actually came through the door and can be used for dividends, debt, and reinvestment.
When you line up Kagome's cash generation against its current share price, the stock could be a clear 30% undervalued.
Kagome’s Defensive Story Meets Mixed Profit Signals
For investors viewing Kagome as a health focused consumer staples anchor, the latest figures partly support that mindset. Revenue of ¥82,881m and a trailing net margin of 4.2% point to a business that is still generating steady cash rather than showing stress. The share price drifting only slightly over the past week and up over 90 days suggests the market is treating this as a stable, slow burn story rather than a broken one.
Profit Slippage Keeps Kagome’s Risk Narrative Alive
Bears find some support as well. Net income excluding extra items declined to ¥3,865m and basic EPS slipped to ¥42.73, which indicates that profitability is under pressure even as sales hold up. That combination aligns with concerns about input costs and competitive categories. The flat margin level suggests that Kagome is not in a crisis, but it is also not clearly reclaiming earlier earnings power, so execution risk around profit quality remains a live issue.
With Kagome showing steady margins but only modest earnings momentum, the real question is whether its balance sheet and cash flows quietly limit future options. Check the full solvency, dividend cover, and debt capacity breakdown in our financial health analysis of Kagome stockHunt Quiet Earnings Disconnects
Kagome just showed how earnings strength and share price can pull in different directions. The real opportunity could be spotting stocks that look mispriced before investors broadly re-rate them.
- Company 1 - 36% below our estimate - focus on complex public works where long term maintenance contracts follow initial construction.
- Company 2 - 44% below our estimate - build recurring IT services around mobility, cloud and DX projects once clients expand beyond one off development.
- Company 3 - 34% below our estimate - supply niche optical and electronic materials that device makers adopt when legacy components constrain new product designs.
Those are three of them. See all 15 potentially undervalued companies →
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com